Close Menu

Precision Oncology News

At the annual meeting, researchers demonstrated how the growing real-world database can be useful in answering myriad research questions.

The firm presented evidence that its DetermaIO gene expression test can help predict which bladder cancer patients are likely to respond to immune checkpoint inhibitors.

At the AACR Annual Meeting, Sharpless said NCI should focus on improving early screening, access to trials, and development of advanced drugs to realize President Biden's goal of eradicating cancer.